Editor’s Pick
Jan 30, 2026
Coverage Universe
Publishing biotech research since 2019. Sponsored and unsponsored.
We focus on micro-cap and small-cap names.
We distill complicated biotech ideas into an understandable narrative.
Editor's Picks
Editor’s Pick
Oct 29, 2025
Editor’s Pick
Jul 17, 2025
Ovid and Xenon: Too Early to Draw Parallels?
$DCTH · $DRUG · $NKTR · $OVID · $SLNO · $XENE
Read full piece →All Coverage
Sorted by date, newest first
Aug 19, 2026
Talphera: Approaching The Pivotal Readout With CorMedix At The Table
Read piece →Jul 29, 2026
Final Obstacle Overcome: Entera Financed For Phase 3
Read piece →Jul 14, 2026
2H2026 Catalyst Cluster
$ABOS, $EPRX, $MSLE, $OVID, $PMN, $XENE
Read piece →May 22, 2026
Protara at a Crossroads
Read piece →Apr 27, 2026
Equillium’s Turnaround: AHR, Abivax, and ADAR1
Read piece →Apr 10, 2026
Rapid Fire Therapy: Quick Updates From Our Biotech Universe
$EPRX, $MSLE, $OVID, $PMN, $RNXT
Read piece →Mar 20, 2026
Playbooks & Predictions: Xenon, Praxis, and Ovid
Read piece →Feb 20, 2026
Predicting Protara: Impending Data at Next Week’s ASCO-GU
Read piece →Jan 30, 2026